Cgenetix
Paris, FR · 1 known investors
CGenetix develops liquid biopsy biomarkers using circulating cell-free DNA to detect organ damage, with a focus on transplantation (kidney, lung, pancreas) rejection diagnostics. The company applies techniques such as digital PCR, NGS and bioinformatics to build in vitro diagnostic tests for the medical and clinical community.
Founders & leadership
GP
Geoffroy PouletCEO & Co-founder
Y
YoanCSO & Co-founder